HIV Prevention Interventions for African American Injection Drug Users

  • David W. Purcell
  • Yuko Mizuno
  • Cynthia M. Lyles


Injection drug use has been a major risk factor for transmission of HIV in the United States since the beginning of the HIV epidemic (Des Jarlais & Semaan, 2008) and is a major risk factor for African Americans. While the proportion of injection drug users (IDUs) among HIV-positive persons has decreased over time, the Centers for Disease Control and Prevention (CDC) reported that, at the end of 2007, IDUs accounted for 23% of existing AIDS cases in the United States (30% if men who have sex with men (MSM) and inject drugs are included) (CDC, 2009). By gender, 35% of overall AIDS cases among women and 20% among men are attributed to drug injection (29% among men if MSM/IDUs are included) (CDC, 2009). African Americans are disproportionately affected by HIV and AIDS – in 2006 African American accounted for approximately 12% of the population and 46% of the persons estimated to be living with HIV (CDC, 2008). When looking at the percent of reported AIDS cases attributed to injection drug use within race and gender, it is much higher among African American men (29%) than among white, non Hispanics men (9%) while the percent of AIDS cases attributed to IDUs is similarly high for African American women (33%) and white women (40%) and also is similar among MSM/IDUs for African American men (8%) and white men (9%) (CDC, 2009). For both African American men and women, IDU is the second leading transmission risk category (CDC, 2009).


Sexual Risk African American Woman Sexual Risk Behavior Injection Risk Replicate Effective Program 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Academy for Educational Development. (2009). DEBI – Diffusion of Effective behavioral interventions website. Accessed March 16, 2009 from
  2. Armstrong, G. L. (2007). Injection drug users in the United States, 1979–2002: An aging population. Archives of Internal Medicine, 167, 166–173.Google Scholar
  3. Blankenship, K. M., Smoyer, A. B., Bray, S. J., & Mattocks, K. (2005). Black-White disparities in HIV/AIDS: The role of drug policy and the corrections system. Journal of Health Care for Poor and Underserved, 16(4 Suppl B), 140–156.Google Scholar
  4. Broz, D., & Ouellet, L. J. (2008). Racial and ethnic changes in heroin injection in the United States: Implications for the HIV/AIDS epidemic. Drug and Alcohol Dependence, 94, 221–233.PubMedCrossRefGoogle Scholar
  5. Centers for Disease Control and Prevention. (2007). Syringe exchange programs – United States, 2005. MMWR. Morbidity and Mortality Weekly Report, 56, 1164–1167.Google Scholar
  6. Centers for Disease Control and Prevention. (2008). HIV prevalence estimates – United States, 2006. MMWR. Morbidity and Mortality Weekly Report, 57, 1073–1076.Google Scholar
  7. Centers for Disease Control and Prevention. (2009). HIV/AIDS Surveillance Report, 2007 (Vol. 19). Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention.Google Scholar
  8. Centers for Disease Control and Prevention. (2010a). Compendium of evidence-based HIV prevention interventions. Atlanta, GA: Centers for Disease Control and Prevention. (July 19, 2010). Scholar
  9. Centers for Disease Control and Prevention. (2010b). Provisional procedural guidance for community based organizations. Atlanta, GA: Centers for Disease Control and Prevention. (July 10, 2010). Scholar
  10. Collins, C., Harshbarger, C., Sawyer, R., & Hamdallah, M. (2006). The diffusion of effective behavioral interventions project: Development, implementation, and lessons learned. AIDS Education and Prevention, 18(Suppl A), 5–20.Google Scholar
  11. Copenhaver, M. M., Johnson, B. T., Lee, I.-C., Harman, J. J., Carey, M. P., & SHARP Research Team. (2006). Behavioral HIV risk reduction among people who inject drugs: Meta-analytic evidence of efficacy. Journal of Substance Abuse Treatment, 31, 163–171.PubMedCrossRefGoogle Scholar
  12. Crepaz, N., Marshall, K. J., Aupont, L. W., Jacobs, E. D., Mizuno, Y., Kay, L. S., et al. (2009). The efficacy of HIV/STI behavioral interventions for African-American females in the United States: A meta-analysis. American Journal of Public Health, 99, 1–10.Google Scholar
  13. Des Jarlais, D. C., & Friedman, S. R. (1996). HIV epidemiology and interventions among injection drug users. International Journal of STDs and AIDS, 7(Suppl 2), 57–61.CrossRefGoogle Scholar
  14. Des Jarlais, D. C., & Semaan, S. (2005). Interventions to reduce the sexual risk behaviour of injection drug users. International Journal of Drug Policy, 16S, S58–S66.CrossRefGoogle Scholar
  15. Des Jarlais, D. C., & Semaan, S. (2008). HIV prevention for injection drug users: The first 25 years and counting. Psychosomatic Medicine, 70, 606–611.PubMedCrossRefGoogle Scholar
  16. Donoghoe, M. C., Verster, A., Pervilhac, C., & Williams P. (2008). Setting targets for universal access to HIV prevention, treatment and care for injecting drug users (IDUs): Towards consensus and improved guidance. International Journal of Drug Policy, 19(Suppl 1) 1, S5–S14.Google Scholar
  17. Eke, A. N., Neumann, M. S., Wilkes, A. L., & Jones, P. L. (2006). Preparing effective behavioral interventions to be used by prevention providers: The role of researchers during HIV prevention research trials. AIDS Education and Prevention, 18(Suppl A), 44–58.Google Scholar
  18. Estrada, A. L. (2005). Health disparities among African-American and Hispanic drug injectors – HIV, AIDS, hepatitis B virus and hepatitis C virus: a review. AIDS, 19(Suppl 3), S47–S52.PubMedCrossRefGoogle Scholar
  19. Farrell, M., Gowing, L., Marsden, J., Ling, W., & Ali, R. (2005). Effectiveness of drug dependence treatment in HIV prevention. International Journal of Drug Policy, 16, 67–75.CrossRefGoogle Scholar
  20. Garfein, R. S., Golub, E. T., Greenberg, A. E., Hagan, H., Hanson, D. L., Hudson, S. M., Kapadia, F., Latka, M. H., Ouellet, L. J., Purcell, D. W., Strathdee, S. A., Thiede, H., for the DUIT Study Team. (2007). A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS, 21, 1923–1932.Google Scholar
  21. Gibson, D. R., Flynn, N. R., & Perales, D. (2001). Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS, 15, 1329–1341.PubMedCrossRefGoogle Scholar
  22. Hershberger, S. L., Wood, M. M., & Fisher, D. G. (2003). A cognitive-behavioral intervention to reduce HIV risk behaviors in crack and injection drug users. AIDS and Behavior, 7, 229–243.Google Scholar
  23. Hogben, M., & Leichliter, J. S. (2008). Social determinants and sexually transmitted disparities. Sexually Transmitted Diseases, 35, S13–S18.PubMedCrossRefGoogle Scholar
  24. Huo, D., & Ouellet, L. J. (2007). Needle exchange and injection-related risk behaviors in Chicago: A longitudinal study. Journal of Acquired Immune Deficiency Syndromes, 45, 108–114.PubMedCrossRefGoogle Scholar
  25. Jones, T. S., & Coffin, P. O. (2002). Preventing blood-borne infections through pharmacy syringe sales and safe community syringe disposal. Journal of the American Pharmaceutical Association, 42(Suppl 2), S6–S9.PubMedCrossRefGoogle Scholar
  26. Kotranski, L., Semaan, S., Collier, K., Lauby, J., Halbert, J., & Feighan, K. (1998). Effectiveness of an HIV risk reduction counseling intervention for out-of-treatment drug users. AIDS Education and Prevention, 10, 19–33.PubMedGoogle Scholar
  27. Kral, A. H., Bluthenthal, R. N., Lorvick, J., Gee, L., Bacchetti, P., & Edlin, B. R. (2001). Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk-factor analysis. Lancet, 357, 1397–1401.PubMedCrossRefGoogle Scholar
  28. Ksobiech, K. (2003). A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. AIDS Education and Prevention, 15, 257–268.PubMedCrossRefGoogle Scholar
  29. Latka, M. H., Hagan, H., Kapadia, F., Golub, E. T., Bonner, S., Campbell, J. V., Coady, M., Garfein, R. S., Pu, M., Thomas, D. L., Thiel, T. K., & Strathdee, S. A. (2008). A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C. American Journal of Public Health, 98, 853–861.Google Scholar
  30. Latkin, C. A., Sherman, S., & Knowlton, A. (2003). HIV prevention among drug users: Outcome of a network-oriented peer outreach intervention. Health Psychology, 22, 332–339.PubMedCrossRefGoogle Scholar
  31. Lyles, C. M., Crepaz, N., Herbst, J. H., Kay, L. S., & HIV/AIDS Prevention Research Synthesis Team. (2006). Evidence-based HIV behavioral prevention from the perspective of CDC’s HIV/AIDS Prevention Research Synthesis Team. AIDS Education and Prevention, 18(Suppl A), 21–31.PubMedCrossRefGoogle Scholar
  32. Magura, S., Kang, S. Y., & Shapiro, J. L. (1994). Outcomes of intensive AIDS education for male adolescent drug users in jail. Journal of Adolescent Health, 15, 457–463.Google Scholar
  33. Margolin, A., Avants, S. K., Warburton, L. A., Hawkins, K. A., & Shi, J. (2003). A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychology, 22, 223–228.PubMedCrossRefGoogle Scholar
  34. Mays, V. M., Cochran, S. D., & Barnes, N. W. (2007). Race, race-based discrimination, and health outcomes among African Americans. Annual Review of Psychology, 58, 201–225.Google Scholar
  35. McKleroy, V. S., Galbraith, J. S., Cummings, B., Jones, P., Harshbarger, C., Collins, C., Gelaude, D., Carey, J. W., & the ADAPT Team. Adapting evidence-based behavioral interventions for new settings and target populations. AIDS Education and Prevention, 18(Suppl A), 59–73.Google Scholar
  36. McMahon, R. C., Malow, R. M., Jennings, T. E., & Gomez, C. J. (2001). Effects of a cognitive-behavioral HIV prevention intervention among HIV negative male substance abusers in VA residential treatment. AIDS Education and Prevention, 13, 91–107.PubMedCrossRefGoogle Scholar
  37. Metzger, D., Navaline, H., & Woody, G. (1998). Drug abuse treatment as AIDS prevention. Public Health Reports, 113(Suppl 1), 97–106.PubMedGoogle Scholar
  38. Mizuno, Y., Purcell, D., Borkowski, T. M., Knight, K., & SUDIS Team. (2003). The life priorities of HIV-seropositive injection drug users: Findings from a community-based sample. AIDS and Behavior, 7, 395–403.PubMedCrossRefGoogle Scholar
  39. Mizuno, Y., Wilkinson, J. D., Santibanez, S., Dawson Rose, C., Knowlton, A., Handley, K., et al. (2006). Correlates of health care utilization among HIV-seropositive injection drug users. AIDS Care, 18, 417–425.PubMedCrossRefGoogle Scholar
  40. Needle, R. H., Burrows, D., Friedman, S. R., Dorabjee, J., Touze, G., Badrieva, L., et al. (2005). Effectiveness of community-based outreach in preventing HIV/AIDS among injection drug users. International Journal of Drug Policy, 16S, S45–S57.CrossRefGoogle Scholar
  41. Prendergast, M. L., Urada, D., & Podus, D. J. (2001). Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs. Journal of Consulting and Clinical Psychology, 69, 389–405.PubMedCrossRefGoogle Scholar
  42. Prochaska, J. O., DiClemente, C. C., & Norcross, J. C. (1992). In search of how people change. American Psychologist, 47, 1101–1113.CrossRefGoogle Scholar
  43. Purcell, D. W., Latka, M. H., Metsch, L. R., Latkin, C. A., Gomez, C. A., Mizuno, Y., et al. (2007). Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. Journal of Acquired Immune Deficiency Syndromes, 46(Suppl 2), S35–S47.PubMedCrossRefGoogle Scholar
  44. Purcell, D. W., Metsch, L., Latka, M., Santibanez, S., Eldred, L., Gomez, C. A., et al. (2004). Behavioral prevention trial with HIV-seropositive injection drug users: Rationale and methods of the INSPIRE Study. Journal of Acquired Immune Deficiency Syndromes, 37(Suppl 2), S110–S118.PubMedCrossRefGoogle Scholar
  45. Rich, J. D., Hogan, J. W., Wolf, F., DeLong, A., Zaller, N. D., Mehrotra, M., & Reinhert, S. (2007). Lower syringe sharing and re-use after syringe legalization in Rhode Island. Drug and Alcohol Dependence, 89, 292–297.Google Scholar
  46. Semaan, S., Des Jarlais, D. C., Sogolow, E., Johnson, W. D., Hedges, L. V., Ramirez, G., et al. (2002). A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. Journal of Acquired Immune Deficiency Syndromes, 30, S73–S93.PubMedGoogle Scholar
  47. Sterk, C. E., Theall, K. P., Elifson, K. W., & Kidder, D. (2003). HIV risk reduction among African American women who inject drugs: A randomized controlled trial. AIDS and Behavior, 7, 73–86.PubMedCrossRefGoogle Scholar
  48. Stratford, D., Mizuno, Y., Williams, K., Courtenay-Quirk, C., & O’Leary, A. (2008). Addressing poverty as a risk for disease: Recommendations from the CDC’s consultation on microenterprise as HIV prevention. Public Health Reports, 123, 9–20.PubMedGoogle Scholar
  49. Strathdee, S. A., & Sherman, S. G. (2003). The role of sexual transmission of HIV infection among injection and non-injection drug users. Journal of Urban Health, 2003(80), 7–14.Google Scholar
  50. The CDC AIDS Community Demonstration Projects Research Group. (1999). Community-level HIV intervention in 5 cities: Final outcome data from the CDC AIDS community demonstration projects. American Journal of Public Health, 89, 336–345.CrossRefGoogle Scholar
  51. Watters, J. K., Bluthenthal, R. N., & Kral, A. H. (1995). HIV seroprevalence in injection drug users. Journal of the American Medical Association, 273, 1178.Google Scholar
  52. Wechsberg, W. M., Lam, W. K., Zule, W. A., & Bobashev, G. (2004). Efficacy of a woman focused intervention to reduce HIV risk and increase self-sufficiency among African American crack abusers. American Journal of Public Health, 94, 1165–1173.Google Scholar
  53. Weinhardt, L., Carey, M., Johnson, B., & Bickham, N. (1999). Effects of HIV counseling and testing on sexual risk behavior: A meta-analytic review of published research, 1985–1997. American Journal of Public Health, 89, 1397–1404.PubMedCrossRefGoogle Scholar
  54. Weissman, G., & Brown, V. (1995). Drug using women and HIV risk reduction and prevention issues. In A. O’Leary & L. S. Jemmott (Eds.), Women at risk: Issues in the primary prevention of AIDS (pp. 175–193). New York: Plenum.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • David W. Purcell
    • 1
  • Yuko Mizuno
  • Cynthia M. Lyles
  1. 1.Division of HIV/AIDS PreventionCenters for Disease ControlAtlantaUSA

Personalised recommendations